Osimertinib in patients with advanced/metastatic epidermal growth factor receptor T790M mutation-positive non-small cell lung cancer - the Belgian ASTRIS data. - Colinet B; Van Meerbeeck JP; Cuppens T; Vansteenkiste JF (Acta clinica Belgica, 2021)